A Philadelphia Commerce Court judge has ordered reopened the deposition of a corporate vice president in a $51 million wholesale pharmaceuticals dispute after finding there is “reasonable suspicion” that counsel for the executive’s company coached the man during breaks in that original deposition.
Philadelphia Common Pleas Judge Howland W. Abramson’s recent decision in AmerisourceBergen Drug Corp. v. Curascript Inc. casts a spotlight on U.S. courts’ lack of a uniform set of rules governing conduct in depositions.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
